Federal Circuit: Proposed Generic Drug Does Not Meet Patent Limitations

(February 13, 2017, 10:51 AM EST) -- WASHINGTON, D.C. — A Florida federal judge erred in concluding that an abbreviated new drug application (ANDA) satisfies various Markush group requirements set forth in claim 1(b) of a drug composition...
To view the full article, register now.